Synthadon 10 mg/ml Solution for Injection for Cats and Dogs
Active ingredient: Methadone Hydrochloride
Form
Injection
Species
Manufacturer
Le Vet Beheer B.V.
VMD MA No.
41821/3006
What it's used for
Premedication for general anaesthesia or neuroleptanalgesia in dogs and cats in combination with a neuroleptic drug.
Full indications, dosage and side effects ↓The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.
Paying less for Methadone Hydrochloride
-
1
Ask your vet for a written prescription
They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
-
2
Fill it at a registered online retailer
The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.
Done — we'll email you when prices land.
Prescription required
Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.
Synthadon 10 mg/ml Solution for Injection for Cats and Dogs — SPC Details
Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.
combination with a neuroleptic drug.
Intramuscular use.
To ensure accuracy of dosing, bodyweight should be accurately measured and an
appropriately calibrated syringe should be used to administer the veterinary
medicinal product.
Analgesia
Dogs: 0.5 to 1 mg methadone hydrochloride per kg bodyweight, subcutaneously,
intramuscularly or intravenously (corresponding to 0.05 to 0.1 ml/kg)
Cats: 0.3 to 0.6 mg methadone hydrochloride per kg bodyweight, intramuscularly
(corresponding to 0.03 to 0.06 ml/kg)
As the individual response to methadone is varied, and depends partly on the
dosage, the age of the patient, individual differences in pain sensitivity and general
condition the optimal dosing regimen should be individually based. In dogs onset of
action is 1 hour following subcutaneous administration, approximately 15 minutes
following intramuscular injection and within 10 minutes following intravenous
injection. Duration of effect is approximately 4 hours following intramuscular or
intravenous administration. In cats onset of action is 15 minutes following
administration and the duration of effect is 4 hours in average. The animal should be
examined regularly to assess if additional analgesia is subsequently required.
Premedication and/or neuroleptanalgesia
Dogs:
• Methadone HCl 0.5-1 mg/kg, IV, SC or IM
Combinations e.g.:
• Methadone HCl 0.5 mg/kg, IV + e.g. midazolam or diazepam
Induction with propofol, maintenance on isoflurane in oxygen.
• Methadone HCl 0.5 mg/kg + e.g acepromazine
Induction with thiopentone or propofol to effect, maintenance on isoflurane in oxygen
or induction with diazepam and ketamine
• Methadone HCl 0.5 -1.0 mg/kg, IV or IM + α2-agonist (e.g. xylazine or
medetomidine)
Induction with propofol, maintenance with isoflurane in combination with fentanyl or
total intravenous anaesthesia (TIVA) protocol: maintenance with propofol in
combination with fentanyl
TIVA protocol: induction propofol, to effect. Maintenance with propofol and
remifentanil
Chemical-physical compatibility has only been demonstrated for dilutions 1:5 with the
following solutions for infusion: sodium chloride 0.9%, Ringer solution, and glucose
5%.
Cats:
• Methadone HCl 0.3 to 0.6 mg/kg, IM
- Induction with Benzodiazepine (e.g. midazolam) and dissociative (e.g.
ketamine);
- With a tranquilizer (e.g. acepromazine) and NSAID (meloxicam) or sedative
(e.g. α2-agonist);
- Induction with propofol, maintenance with isoflurane in oxygen.
Doses depend on the desired degree of analgesia and sedation, desired duration of
effect and the concurrent use of other analgesics and anaesthetics.
When used in combination with other products, lower dosages can be used.
For safe use with other pharmaceuticals, reference must be made to the relevant
product literature.
The stopper should not be punctured more than 20 times.
excipients.
Do not use in animals with advanced respiratory failure.
Do not use in animals with severe liver and renal dysfunction.
Very common
(>1 animal / 10 animals
treated):
Lip licking
1,2
, diarrhoea
1,2
, involuntary defecation
1,2
Respiratory depression
Vocalisation
1,2
Urination
1,2
Mydriasis
1,2
Hyperthermia
1,2
Hypersensitivity to pain
1
Mild
Transient
Dogs:
Very common
(>1 animal / 10 animals
treated):
Respiratory depression
, panting
1,2
, irregular
breathing
1,2
Bradycardia
Lip licking
1,2
, hypersalivation
1,2
Vocalisation
1,2
Hypothermia
1,2
Staring
1,2
, Tremor
1,2
Very rare
(<1 animal / 10,000 animals
treated, including isolated
reports):
Urination
2,3
Involuntary defecation
2,3
Mild
Transient
Within first hour post dose
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or its local representative or the national
competent authority via the national reporting system. See the package leaflet for
respective contact details.
monitored to ensure sufficient efficacy for the desired effect duration. Use of the
veterinary medicinal product must be preceded by a thorough clinical examination. In
cats pupil dilatation is seen long after the analgesic effect has disappeared. It is
therefore not an adequate parameter to assess clinical efficacy of the administered
dose.
Greyhounds may require higher doses than other breeds to achieve efficacious
plasma levels.
Special precautions for safe use in the target species:
Methadone may occasionally cause respiratory depression and as with other opioid
drugs, care should be taken when treating animals with impaired respiratory function
or animals that are receiving drugs that can cause respiratory depression. To ensure
safe use of the veterinary medicinal product, treated animals should be monitored
regularly, including examination of heart rate and respiratory rate.
As methadone is metabolised by the liver, its intensity and duration of action may be
affected in animals with impaired liver function. In case of renal, cardiac or hepatic
dysfunction or shock, there may be greater risk associated with the use of the
veterinary medicinal product. The safety of methadone has not been demonstrated in
dogs less than 8 weeks and cats less than 5 months of age. The effect of an opioid
on head injury is dependent on the type and severity of the injury and the respiratory
support supplied. Safety has not been fully evaluated in clinically compromised cats.
Due to the risk of excitation, repeated administration in cats should be used with
care. Use in the above mentioned cases should be in accordance with a benefit/risk
assessment by the responsible veterinarian.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals:
Methadone can cause respiratory depression following spillage on the skin or
accidental self-injection. Avoid skin, eyes and mouth contact and personal protective
equipment consisting of impermeable gloves should be worn when handling the
veterinary medicinal product. In case of spilling on the skin or splashing in the eyes,
wash immediately with large amounts of water. Remove contaminated clothes.
People with known hypersensitivity to methadone should avoid contact with the
veterinary medicinal product. Methadone has the potential to cause stillbirths.
Pregnant women are advised not to handle the veterinary medicinal product.
In case of accidental self-injection, seek medical advice immediately and show the
package leaflet or the label to the physician but DO NOT DRIVE as sedation may
occur.
To the physician:
Methadone is an opioid whose toxicity may cause clinical effects including respiratory
depression or apnoea, sedation, hypotension and coma. When respiratory
depression occurs controlled ventilation should be initiated. Administration of the
opioid antagonist naloxone to reverse the symptoms is recommended.
Special precautions for the protection of the environment:
Not applicable.
This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.
Medication costs adding up?
Pet insurance can cover prescription medications. Find the right policy for your pet.
Related Conditions
Other Products Containing Methadone Hydrochloride
These products share the same active ingredient and may be suitable alternatives. Always consult your vet.
Comfortan 10 mg/ml, Solution for Injection for Dogs and Cats
POM-VEurovet Animal Health B.V.
Comfortan 10 mg/ml, Solution for Injection for Dogs and Cats
POM-VEurovet Animal Health B.V.
Insistor 10 mg/ml Solution for Injection for Dogs and Cats
POM-VVetViva Richter GmbH
Methadyne 10 mg/ml Solution for Injection for Dogs and Cats
POM-VZoetis UK Limited
Synthadon 10 mg/ml Solution for Injection for Cats and Dogs
POM-VLe Vet Beheer B.V.
Synthadon 5 mg/ml Solution for Injection for Cats and Dogs
POM-VLe Vet Beheer B.V.
Alternative options to consider
Retailers we earn a commission from. It costs you nothing and never changes what we show.
The Pharm Pet Co. — Pet Pharmacy
UK online pet pharmacy. Flea, worm, prescription medications, supplements and pet food. Save vs vet prices.
Pet Care at Pharmacy2U
The UK's largest online pharmacy. Pet wormers, flea treatments, dental and joint care. Free delivery on orders over £30.
Petlibro Automatic Feeder
Smart automatic pet feeder with app control. Schedule meals, portion control, and feeding history.
We may earn a small commission if you purchase through these links, at no extra cost to you.
Related Medications
Alvegesic Vet. 10 mg/ml Solution for Injection for Horses, Dogs and Cats
POM-VButorphanol
Alvegesic Vet. 10 mg/ml Solution for Injection for Horses, Dogs and Cats
POM-VButorphanol
Bupaq 0.3 mg/ml Solution for Injection for Dogs and Cats
POM-VBuprenorphine
Bupaq Multidose 0.3 mg/ml Solution for Injection for Dogs and Cats
POM-VBuprenorphine
Buprecare 0.3 mg/ml Solution for Injection for Dogs and Cats
POM-VBuprenorphine
Buprecare Multidose 0.3 mg/ml Solution for Injection for Dogs and Cats
POM-VBuprenorphine
Find cheaper vets near you
Compare vet consultation prices in your area. Save on procedures and get a prescription to buy medications online.